199 related articles for article (PubMed ID: 27535684)
41. Evaluating the aptima HIV-1 quant Dx, HCV quant Dx and HBV quant assays against the Abbott HIV-1, HCV and HBV RealTime assays.
May S; Adamska E; Tang JW
J Clin Virol; 2018 Sep; 106():7-10. PubMed ID: 30007139
[TBL] [Abstract][Full Text] [Related]
42. Comparison of Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 (CAP/CTM v2.0) with other real-time PCR assays in HIV-1 monitoring and follow-up of low-level viral loads.
Wojewoda CM; Spahlinger T; Harmon ML; Schnellinger B; Li Q; Dejelo C; Schmotzer C; Zhou L
J Virol Methods; 2013 Jan; 187(1):1-5. PubMed ID: 23098667
[TBL] [Abstract][Full Text] [Related]
43. Comparison of the Aptima HIV-1 Quant Dx assay with the COBAS AmpliPrep/COBAS TaqMan HIV-1 v2.0 Test for HIV-1 viral load quantification in plasma samples from HIV-1-infected patients.
Longo S; Bon I; Musumeci G; Bertoldi A; D'Urbano V; Calza L; Re MC
Health Sci Rep; 2018 Apr; 1(4):e31. PubMed ID: 30623066
[TBL] [Abstract][Full Text] [Related]
44. Establishing diagnostic cut-off criteria for the COBAS AmpliPrep/COBAS TaqMan HIV-1 Qualitative test through validation against the Amplicor DNA test v1.5 for infant diagnosis using dried blood spots.
Maritz J; Preiser W; van Zyl GU
J Clin Virol; 2012 Feb; 53(2):106-9. PubMed ID: 22196872
[TBL] [Abstract][Full Text] [Related]
45. Dried blood spot specimens are a suitable alternative sample type for HIV-1 viral load measurement and drug resistance genotyping in patients receiving first-line antiretroviral therapy.
Rottinghaus EK; Ugbena R; Diallo K; Bassey O; Azeez A; Devos J; Zhang G; Aberle-Grasse J; Nkengasong J; Yang C
Clin Infect Dis; 2012 Apr; 54(8):1187-95. PubMed ID: 22412066
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of dried blood spot diagnosis using HIV1-DNA and HIV1-RNA Biocentric assays in infants in Abidjan, Côte d'Ivoire. The Pedi-Test DBS ANRS 12183 Study.
Yapo V; d'Aquin Toni Td; Desmonde S; Amani-Bosse C; Oga M; Lenaud S; Menan H; Timité-Konan M; Leroy V; Rouzioux C
J Virol Methods; 2013 Nov; 193(2):439-45. PubMed ID: 23872283
[TBL] [Abstract][Full Text] [Related]
47. Laboratory evaluation of the Liat HIV Quant (IQuum) whole-blood and plasma HIV-1 viral load assays for point-of-care testing in South Africa.
Scott L; Gous N; Carmona S; Stevens W
J Clin Microbiol; 2015 May; 53(5):1616-21. PubMed ID: 25740777
[TBL] [Abstract][Full Text] [Related]
48. Improved Sensitivity of a Dual-Target HIV-1 Qualitative Test for Plasma and Dried Blood Spots.
Templer SP; Seiverth B; Baum P; Stevens W; Seguin-Devaux C; Carmona S
J Clin Microbiol; 2016 Jul; 54(7):1877-1882. PubMed ID: 27194686
[TBL] [Abstract][Full Text] [Related]
49. HIV-1 variability and viral load technique could lead to false positive HIV-1 detection and to erroneous viral quantification in infected specimens.
Alvarez P; Martín L; Prieto L; Obiang J; Vargas A; Avedillo P; Rojo P; Fernández McPhee C; Benito A; Ramos JT; Holguín Á
J Infect; 2015 Sep; 71(3):368-76. PubMed ID: 26033694
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of an affordable HIV-1 virological failure assay and antiretroviral drug resistance genotyping protocol.
Bronze M; Aitken SC; Wallis CL; Steegen K; Stuyver LJ; de Wit TF; Stevens W
J Virol Methods; 2013 Dec; 194(1-2):300-7. PubMed ID: 23994150
[TBL] [Abstract][Full Text] [Related]
51. Comparison of the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 test v1.0 with v2.0 in HIV-1 viral load quantification.
Tung YC; Ke LY; Lu PL; Lin KH; Lee SC; Lin YY; Chou LC; Tsai WC
Kaohsiung J Med Sci; 2015 Apr; 31(4):188-93. PubMed ID: 25835274
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of the Aptima HBV Quant assay vs. the COBAS TaqMan HBV test using the high pure system for the quantitation of HBV DNA in plasma and serum samples.
Schalasta G; Börner A; Speicher A; Enders M
Clin Chem Lab Med; 2018 Mar; 56(4):634-641. PubMed ID: 29197859
[TBL] [Abstract][Full Text] [Related]
53. Performance of Roche CAP/CTM HIV-1 qualitative test version 2.0 using dried blood spots for early infant diagnosis.
Gueye SB; Diop-Ndiaye H; Diallo MM; Ly O; Sow-Ndoye A; Diagne-Gueye ND; Kébé-Fall K; Diop F; Gaye-Diallo A; Belec L; Mboup S; Touré-Kane C
J Virol Methods; 2016 Mar; 229():12-5. PubMed ID: 26706730
[TBL] [Abstract][Full Text] [Related]
54. Comparison of the RealTime HIV-1, COBAS TaqMan 48 v1.0, Easy Q v1.2, and Versant v3.0 assays for determination of HIV-1 viral loads in a cohort of Canadian patients with diverse HIV subtype infections.
Church D; Gregson D; Lloyd T; Klein M; Beckthold B; Laupland K; Gill MJ
J Clin Microbiol; 2011 Jan; 49(1):118-24. PubMed ID: 21084515
[TBL] [Abstract][Full Text] [Related]
55. Higher specificity of nucleic acid sequence-based amplification isothermal technology than of real-time PCR for quantification of HIV-1 RNA on dried blood spots.
Mercier-Delarue S; Vray M; Plantier JC; Maillard T; Adjout Z; de Olivera F; Schnepf N; Maylin S; Simon F; Delaugerre C
J Clin Microbiol; 2014 Jan; 52(1):52-6. PubMed ID: 24131691
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of the use of plasma preparation tubes for HIV viral load testing on the COBAS AmpliPrep/COBAS TaqMan HIV-1 version 2.0.
Goedhals D; Scott LE; Moretti S; Cooper MA; Opperman WJ; Rossouw I
J Virol Methods; 2013 Feb; 187(2):248-50. PubMed ID: 23178587
[TBL] [Abstract][Full Text] [Related]
57. Performance of the automated COBAS AmpliPrep/COBAS TaqMan HIV-1 test on a genetically diverse panel of specimens from China: comparison to the COBAS amplicor HIV-1 monitor test, v1.5.
Xu S; Song A; Li X; Nie J; Zhang C; Wang Y
Intervirology; 2010; 53(4):221-8. PubMed ID: 20332651
[TBL] [Abstract][Full Text] [Related]
58. Correlation between HIV-1 viral load quantification in plasma, dried blood spots, and dried plasma spots using the Roche COBAS Taqman assay.
Andreotti M; Pirillo M; Guidotti G; Ceffa S; Paturzo G; Germano P; Luhanga R; Chimwaza D; Mancini MG; Marazzi MC; Vella S; Palombi L; Giuliano M
J Clin Virol; 2010 Jan; 47(1):4-7. PubMed ID: 19962936
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of Performance Characteristics of the Aptima CMV Quant Assay for the Detection and Quantitation of CMV DNA in Plasma Samples.
Sam SS; Rogers R; Ingersoll J; Kraft CS; Caliendo AM
J Clin Microbiol; 2023 Feb; 61(2):e0169922. PubMed ID: 36719219
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of the COBAS(®) AmpliPrep/COBAS(®) TaqMan(®) HCV Test, v2.0 and comparison to assays used in routine clinical practice in an international multicenter clinical trial: The ExPECT study.
Kessler HH; Cobb BR; Wedemeyer H; Maasoumy B; Michel-Treil V; Ceccherini-Nelli L; Bremer B; Hübner M; Helander A; Khiri H; Heilek G; Simon CO; Luk K; Aslam S; Halfon P
J Clin Virol; 2015 Jun; 67():67-72. PubMed ID: 25959162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
